Diclofenac Epolamine System
Product Images NDC 80425-0364

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 80425-0364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diclofenac Epolamine 1.3 System 1 (Diclofenac Epolamine 1.3 System 80425 0364 01)

Packaging label for Diclofenac Epolamine 1.3% Topical System, with a count of 30 patches. Label indicates storage at 20°-25°C and includes caution for patients on blood thinners. It is labeled for prescription use only, manufactured or packed by Advanced Rx of Tennessee, and references a comparative product Flector by Teva USA.*

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure diagram of diclofenac epolamine. The image shows the chemical structures of diclofenac and epolamine components, including a dichlorinated aromatic ring system and a pyrrolidino ethanol group labeled with molecular formula details.*

FDA Label Image

Figure 1 And 2 (Diclofenac 02)

Two line charts comparing patients achieving various levels of pain relief in a 14-day study for diclofenac epolamine patch versus placebo. Figure 1 shows patient improvement at Day 3, displaying higher percentages of patients improved with the diclofenac patch across percent improvements from baseline. Figure 2 shows patient improvement at study end, with the diclofenac patch group consistently showing greater patient improvement percentages than placebo across all improvement levels.*

FDA Label Image

Figure 3 And 4 (Diclofenac 03)

Two side-by-side line graphs showing patient percentages achieving various levels of pain relief during a 7-day study with diclofenac epolamine patch versus placebo. The Y-axis represents the percent of patients improved, and the X-axis represents the percent improvement from baseline. The graphs illustrate higher patient improvement percentages with the diclofenac patch compared to placebo at day 3 and at the end of the study.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.